Minimally Invasive Pancreas Surgery: Is There a Benefit?

Hussein M Hariri1, Samuel B Perez2, Kevin M Turner3

  • 1Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Department of Surgical Oncology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45229, USA.

PubMed

Insights

Minimally invasive pancreas surgery (MIPS) offers perioperative benefits and maintains oncological standards. Further research should address the learning curve for MIPS proficiency.

Area of Science:

  • Surgical innovation and patient outcomes.

Background:

  • Minimally invasive pancreas surgery (MIPS) introduced in 1994 faced skepticism regarding its efficacy versus open surgery.
  • The procedure aims to reduce patient trauma while achieving therapeutic goals.

Purpose of the Study:

  • To evaluate the efficacy and perioperative advantages of MIPS.
  • To explore the conditions under which MIPS maintains oncological standards.

Main Methods:

  • Comparative analysis of minimally invasive versus open pancreas surgery approaches.
  • Review of surgical outcomes and oncological data.

Main Results:

  • MIPS demonstrates perioperative advantages.
  • Oncological outcomes are comparable to open surgery when performed by experienced surgeons.
  • A robust training regimen and frequent practice are crucial for MIPS success.

Conclusions:

  • MIPS is a viable alternative to open pancreas surgery, offering significant benefits.
  • Surgeon training and experience are critical factors in achieving proficiency and optimal outcomes.
  • Future research should focus on the MIPS learning curve and factors influencing technical proficiency.